Dr Ola Engkvist, AstraZeneca, explains how the drug discovery process benefits from artificial intelligence and machine learning.
The Advantages of Machine Learning and Artificial Intelligence in the Drug Discovery Process
Video Nov 20, 2018
The novel coronavirus sweeping the globe packs 27 proteins, each adopting a unique, often incredibly complex 3D structure. Each protein is part of the molecular toolkit that the virus uses to infect, replicate, and spread. Understanding the proteins' structures provides a blueprint for drug designs.WATCH NOW
Dr. Fabiana Quaglia, Associate Professor of Pharmaceutical Technology at the Faculty of Pharmacy–University of Napoli Federico II, Italy discusses how reliability and smart features of the rotary evaporator, Rotavapor® R-300, let her easily evaporate solvents in particle production for cancer and cystic fibrosis drug development and formulation.WATCH NOW